drugset / Trial / NCT00791297
Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to to determine pharmacodynamic effects of a vaginal ring delivering either 1,500 or 2,500 μg of CDB-2914 per day during 6 months of treatment on: 1. follicular function and inhibition of ovulation 2. the endometrium 3. bleeding patterns; and also to assess safety including effects on the endometrium
Timeline
- Start
- 2008-10
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ulipristal Acetate | Unknown | 1500 ug | Other |
| Comparator | Ulipristal Acetate | Unknown | 2500 ug | Other |
Indications
No indication recorded.